Texas Yale Capital Corp’s Precision BioSciences DTIL Stock Holding History

Texas Yale Capital Corp’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-333	Closed	-$3.65K	–	450
2023 Q4	$3.65K	Hold	333	–	–	﹤0.01%	437
2023 Q3	$3.41K	Hold	333	–	–	﹤0.01%	423
2023 Q2	$5.26K	Hold	333	–	–	﹤0.01%	443
2023 Q1	$7.54K	Hold	333	–	–	﹤0.01%	453
2022 Q4	$11.9K	Hold	333	–	–	﹤0.01%	454
2022 Q3	$13K	Hold	333	–	–	﹤0.01%	450
2022 Q2	$16K	Hold	333	–	–	﹤0.01%	445
2022 Q1	$31K	Hold	333	–	–	﹤0.01%	463
2021 Q4	$74K	Hold	333	–	–	﹤0.01%	463
2021 Q3	$115K	Hold	333	–	–	0.01%	447
2021 Q2	$125K	Buy	+333	New	+$100K	0.01%	447

Other funds holding DTIL

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Texas Yale Capital Corp's DTIL Position: Q1 2024 in Review

Texas Yale Capital Corp sold out of Precision BioSciences (DTIL) in Q1 2024, closing a stake of 333 shares — an estimated $3.65K sold.

Texas Yale Capital Corp first reported a position in DTIL in Q2 2021 and held it in 11 quarters. The position peaked at $125K in Q2 2021. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

Texas Yale Capital Corp reported no remaining Precision BioSciences position as of Q1 2024 after selling out during the quarter.
Texas Yale Capital Corp sold 333 Precision BioSciences shares in Q1 2024, an estimated $3.65K.
Texas Yale Capital Corp first reported a position in Precision BioSciences in Q2 2021 and held it in 11 quarters.
Texas Yale Capital Corp's Precision BioSciences position peaked at $125K in Q2 2021.
43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on Texas Yale Capital Corp's 13F filing for Q1 2024, filed 8 May 2024.